Investigation and analysis of one year survival rate and life quality of patients with non-small cell lung cancer treated by different arms

Abstract

Objective To investigate one year survival rate and life quality of patients with non-small cell lung cancer(NSCLC) treated by different arms. Methods One hundred and seventy-nine cases NSCLC patients from January 2013 to December 2014 were selected from the Third Hospital of Tanshan and followed-up, including 57 cases with surgical treatment, 70 cases with the use of Navelbine plus cisplatin, 52 cases with dendritic cells(DC) and cytokine induced killer cells(CIK) immune based therapy(DC/CIK) treatment.After one year period of radiotherapy and chemotherapy, the SF-36 questionnaire was used to investigate the quality of life of the surviving patients, and the quality of life was assessed from three aspects of the physiological, psychological and social functions.To quantify the quality of life score, the 100 percentage grading system was adopted, logistic regression analysis was used to adjust the influence of age and gender on survival rate, and the data were analyzed by SAS 9.2 statistical software package. Results One hundred and seventy-nine subjects were included in this study, by the end of follow-up on December 2015, there were 119 cases survived, the survival rate was 66.5%(119/179). Survival rate of surgical operation group, DC/CIK group and chemotherapy group orderly decreased(82.5%(47/57), 76.9%(40/52) and 45.7%(32/70), P 0.05), but the chemotherapy group was lower(P<0.05); physiological function in the chemotherapy group, operation group and DC/CIK group showed an increasing trend(P<0.05). Conclusion The one year survival rate of NSCLC patients treated by different arms is 66.5%, and the life quality of patients with biological immune therapy method is better. Key words: Non-small cell lung cancer; Survival rate; Life quality; Biological immunotherapy